Old Mission Capital LLC Agios Pharmaceuticals, Inc. Transaction History

Old Mission Capital LLC

  • $4.27 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$41.92 - $58.18 $1.24 Million - $1.72 Million
-29,553 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$52.06 - $61.27 $848,473 - $998,578
16,298 Added 122.96%
29,553 $1.63 Million
Q1 2021

May 14, 2021
BUY
$44.23 - $57.5 $586,268 - $762,162
13,255 New
13,255 $684,000
Q3 2020

Nov 16, 2020
SELL
$33.87 - $55.93 $434,992 - $718,308
-12,843 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$34.45 - $53.48 $442,441 - $686,843
12,843 New
12,843 $687,000

Others Institutions Holding AGIO

# of Institutions
233
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.9B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email